Xolair News
Most Popular Xolair Story
FDA launches Xolair safety probe
FDA is embarking on a safety review of the asthma drug Xolair. At issue: interim findings from a five-year observational study, which suggest an increase in the number of heart problems and strokes Read more...
Latest Headlines
- June 1, 2010
- July 17, 2009
- January 18, 2008
- November 29, 2007
- November 29, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
